跳至主要内容
临床试验/CTRI/2017/07/009087
CTRI/2017/07/009087尚未招募4 期

CLINICAL TRIAL TO EVALUATE EFFICACY & SAFETY OFPALSINURON CAPSULE FOR TREATMENT OF DIABETIC NEUROPATHY - Palsinuron

Ms SG Phyto Pharma Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Metabolically stable diabetic patients with symptomatic diabetic sensorimotor polyneuropathy (DSPN)
  • 2.Patients of either sex between the age group of 35-65 years.
  • 3. HbA1c not exceeding 11

排除标准

  • 1.Patients who are insulin dependent.
  • 2.Patients with other metabolic and endocrinal disorders.
  • 3.Patients with other causes of Polyneuropathy.
  • 4.Patients suffering from infectious diseases.
  • 5.Patients with non healing ulcer/ulcers.
  • 6.Patients with Diabetic Polyneuropathy in stage N3 of Dyckâ??s staging

研究者

发起方
Ms SG Phyto Pharma Private Limited

相似试验